The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering tlr agonists to oncolytic virus-treated mice

Diana M. Rommelfanger, Marta C. Grau, Rosa M. Diaz, Elizabeth Ilett, Luis Alvarez-Vallina, Jill M. Thompson, Timothy J. Kottke, Alan Melcher, Richard G. Vile

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint Dive into the research topics of 'The efficacy versus toxicity profile of combination virotherapy and TLR immunotherapy highlights the danger of administering tlr agonists to oncolytic virus-treated mice'. Together they form a unique fingerprint.

Medicine & Life Sciences